HealthCare Global Enterprises Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of HealthCare Global Enterprises Limited generated cash of $2,845,790,000, which is more than the previous year. Cash used in financing activities reached the amount of -$640,160,000 last year. Net change in cash is therefore -$51,640,000.
Cash Flow
| 2016 | 689.73M | -2.02B | 1.89B |
|---|---|---|---|
| 2018 | 978.13M | -2.81B | 1.61B |
| 2020 | 1.30B | -1.01B | -584.25M |
| 2021 | 1.20B | -1.71B | 1.12B |
| 2023 | 2.51B | -1.33B | -1.40B |
| 2024 | 2.84B | -2.25B | -640.16M |
HCG.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 1.71B | 1.92B | -587.92M | -291.22M | 510.84M | 247.52M |
Operating activities | ||||||
Net income | 677.29M | 448.7M | -2.28B | -1.19B | 271.76M | 50.01M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 1.74B | 1.63B | 1.59B | 1.48B | 714.6M | 449.93M |
Stock-based compensation expense | 78.46M | 65.1M | 19.12M | 28.31M | 27.09M | 5.39M |
| Deferred income tax benefit | 78.46M | 65.1M | 19.12M | 28.31M | 27.09M | 5.39M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -278.2M | -785.48M | -78.48M | -325.83M | -397.93M | -176.87M |
Inventories | -39.5M | -83.1M | 21.5M | 35.14M | -79.3M | 11.57M |
Accounts payable | 99.5M | 563.47M | -528.90M | 181.88M | 0 | 0 |
Cash generated by operating activities | 2.84B | 2.51B | 1.20B | 1.30B | 978.13M | 689.73M |
Investing activities | ||||||
Purchases Of Investments | 0 | -2M | -2.88B | -14.21M | 40.54M | -35M |
Investments In Property Plant And Equipment | -1.85B | -1.33B | -354.24M | -1.07B | -2.56B | -2.13B |
Acquisitions Net | -450M | -20M | -52.48M | 36.43M | -134.95M | 20.39M |
Cash generated by investing activities | -2.25B | -1.33B | -1.71B | -1.01B | -2.81B | -2.02B |
Financing activities | ||||||
Common Stock Issued | 19.49M | 8.9M | 5.19B | 203.18M | 348.1M | 2.71B |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 933.3M | -453.42M | -2.63B | 200.28M | 1.49B | -186.11M |
Cash used in financing activities | -640.16M | -1.40B | 1.12B | -584.25M | 1.61B | 1.89B |
Net Change In Cash | -51.64M | -215.1M | 616.57M | -296.7M | -240.23M | 564.39M |
Cash at end of period | 1.66B | 1.71B | 28.65M | -587.92M | 270.61M | 811.91M |
| Data source | Data source | Data source | Data source | Data source | Data source |